Authors:
ADLER CH
SINGER C
LAW M
OBRIEN C
PEDDER SCJ
DEPTULA D
Citation: Ch. Adler et al., DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUPS, MULTICENTER STUDY OF TOLCAPONE (TASMAR(R)) IN PARKINSONS-DISEASE PATIENTS WITH SINEMET(R)-INDUCED END-OF-DOSE WEARING-OFF, Neurology, 48(3), 1997, pp. 2006-2006
Authors:
KURTH MC
ADLER CH
STHILAIRE M
SINGER C
WATERS C
LEWITT P
CHERNIK DA
DORFLINGER EE
YOO K
LIEBERMAN AN
BREWER M
SAINTHILAIRE M
PERY LM
THOMAS C
TURPIN L
OBRIEN CF
SEEBERGER LC
DUNCAN KL
CAVINESS JN
DOUGLAS M
WHEELER K
RILEY D
RAINEY P
TANNER CM
KELKER K
LEWIS P
TROSCH RM
MISTURA KL
MONTGOMERY EB
LINDSEY B
WEINER W
SHULMAN LM
SHELDON C
WATERS CH
WELSH M
TRUGMAN JM
LANDOW ER
PEDDER SCJ
SHIMON GS
MAGNI G
Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE EXPERIENCING MOTOR FLUCTUATIONS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Neurology, 48(1), 1997, pp. 81-87
Citation: Pkf. Yeung et al., DETERMINATION OF 3,4-DIHYDROXYPHENYLACETIC ACID AND 5-HYDROXYINDOLEACETIC ACID IN HUMAN PLASMA BY A SIMPLE AND RAPID HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY, Journal of pharmaceutical sciences, 85(4), 1996, pp. 451-453